Textual research on Fuxiong.
10.19540/j.cnki.cjcmm.20241115.103
- Author:
Fang-Yuan MU
1
;
Jia-Xin TIAN
1
;
Kun-Yu LI
2
;
Hai-Guang MA
2
;
Feng GAO
1
Author Information
1. Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.
2. Hebei Baicaokangshen Pharmaceutical Co., Ltd. Hengshui 053800, China.
- Publication Type:English Abstract
- Keywords:
Fuxiong;
Ligusticum sinense cv. Chaxiong;
Xiongqiong;
efficacy;
textual research on materia medica
- MeSH:
Drugs, Chinese Herbal/history*;
China;
Medicine, Chinese Traditional/history*;
History, Ancient;
Humans;
History, Medieval;
Plants, Medicinal/chemistry*;
Rhizome/growth & development*
- From:
China Journal of Chinese Materia Medica
2025;50(6):1715-1720
- CountryChina
- Language:Chinese
-
Abstract:
Fuxiong has a long history of cultivation. Since its first record in the Beneficial Formulas from the Taiping Imperial Pharmacy of the Song Dynasty, Fuxiong had always been used by ancient physicians and became a preponderant variety for some reasons during the periods of the Ming Dynasty, Qing Dynasty, and Republic of China. However, as for modern use, only Chuanxiong Rhizoma is valued, and the medicinal value of Fuxiong is gradually being overlooked. This article systematically researches the nomenclature, producing area, origin, and efficacy of Fuxiong, proving that the planting technology of Fuxiong matured in the Song Dynasty at the latest, slightly later than the emergence of Chuanxiong Rhizoma in the Sui and Tang Dynasties. Over the years, the producing area of Fuxiong has not undergone significant changes, and it is mainly cultivated within Jiangxi province. According to the analysis of the origin of Xiongqiong, combined with modern genetic research, it can be basically clarified that the early source of Xiongqiong may not be single. With the popularization of cultivation, Chuanxiong Rhizoma became a Dao-di herb earliest, gradually replacing Xiongqiong and being recognized clinically. After cultivation, the polyploidy of Chuanxiong Rhizoma varieties formed stable inheritance, forming the later Fuxiong. Medical experts have gradually deepened their understanding of the efficacy of Fuxiong. Initially, they believed that it was a substitute for Chuanxiong Rhizoma and had weaker efficacy than Chuanxiong Rhizoma. Medical experts in Jin and Yuan Dynasties such as Zhu Danxi and Dai Sigong believed that Fuxiong was good at relieving stagnation. Books and records of materia medica in the Ming and Qing Dynasties explicitly proposed the great ability of Fuxiong to relieve stagnation. Fuxiong should be distinguished from Chuanxiong Rhizoma when applied, and the application differences should be clearly reflected in medical records. Based on the comprehensive research in this article, it can be concluded that although most of ancient physicians have attached great importance to genuineness of Chuanxiong Rhizoma, Fuxiong, as a dominant variety of traditional application, has a clear historical context and significant efficacy characteristics, worthy of further in-depth study.
